Nick Finer since 2016, has been senior principal clinical scientist with Novo Nordisk, Global Medical Affairs. He is also honorary clinical professor in the National Centre for Cardiovascular Prevention and Outcomes within the Institute of Cardiovascular Science at University College London. Qualifying in biochemistry and medicine at University College London, Finer has held senior clinical and academic appointments as an endocrinologist, obesity and internal medicine physician at UMDS Guy’s and St Thomas’ Hospitals, Luton and Dunstable Hospitals NHS Trust, University of Cambridge and University College Hospital London.
Dr. Finer is an elected fellow of the US Obesity Society, and of the UK Association for Nutrition; in 2013 he received the Bisset Hawkins Medal 'for work in advancing sanitary science or in promoting public health' awarded by the Royal College of Physicians. Finer chaired World Obesity&ndah;Clinical Care until 2015, developing the SCOPE educational programme. He is past-chair of the UK Association for the Study of Obesity. Finer co-authored the Royal College of Physicians report, Action on obesity: comprehensive care for all, was a member of the UK Government Advisory Group on Obesity, the Clinical Reference Group that advised NHS England on commissioning of specialist obesity services, and the NICE Public Health Advisory Group. Finer is editor-in-chief of Clinical Obesity and has published more than 200 peer reviewed papers and lectured extensively on obesity and its complications as an internationally invited speaker.